NT-proBNP, IL-1 RL1 can identify high-risk congenital heart disease in neonates
Automated quantitative tests for NT-proBNP and interleukin 1 receptor-like 1 (IL-1 RL1) can identify high-risk congenital heart disease (CHD) in newborns, according to a study published in JAMA Network Open.
Jun 24, 2024
0
0